Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.
Antimicrob Agents Chemother
; 49(2): 770-2, 2005 Feb.
Article
in En
| MEDLINE
| ID: mdl-15673763
ABSTRACT
Dalbavancin, tested against 146 staphylococci, was more potent than other drugs tested, with an MIC at which 50% of staphylococci were inhibited of 0.03 microg/ml and an MIC at which 90% of staphylococci were inhibited of 0.06 microg/ml by microdilution. For all strains, MICs of vancomycin, linezolid, ranbezolid, oritavancin, daptomycin, and quinupristin-dalfopristin were =4.0 microg/ml. Dalbavancin was bactericidal at four times the MIC against all six strains tested.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Staphylococcus
/
Glycopeptides
/
Anti-Bacterial Agents
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2005
Document type:
Article
Affiliation country:
United States